Peeyush Shrivastava

Co-Founder and Chief Executive Officer

Peeyush has 8 years of experience as a serial medical technology entrepreneur and technologist. He currently serves as the Co-Founder and Chief Executive Officer of Genetesis, where he has raised over $25 million in venture capital financing and led the company through FDA approval and commercial launch of its flagship product, CardioFlux. Prior to Genetesis, Peeyush served as the Co-Founder and Chief Strategy Officer of Proscia, a world leader in digital pathology. Peeyush studied Biomedical Science at The Ohio State University, but left early to pursue his entrepreneurial efforts as a Thiel Fellow.